| Nov'17 | Nov'16 | Nov'15 | Nov'14 | Nov'13 | Nov'12 | Nov'11 | Nov'10 | Nov'09 |
|---|---|---|---|---|---|---|---|---|
Licensing (Note 3) | ||||||||
- | - | - | - | 1,481 | - | - | - | - |
Milestone (Note 3) | ||||||||
- | - | - | - | 43 | - | - | - | - |
Research and development | ||||||||
- | - | - | - | - | 107 | 501 | 1,459 | 630 |
Other incidental services | ||||||||
- | - | - | - | 2 | - | - | - | - |
Revenues | ||||||||
- | - | - | - | 1,527 | 107 | 501 | 1,459 | 630 |
Expenses | ||||||||
Research and development | ||||||||
- | - | - | - | 5,076 | 5,992 | 5,125 | 4,533 | 1,937 |
Selling, general and administrative | ||||||||
- | - | - | - | 2,873 | 3,672 | 2,925 | 2,699 | 975 |
Depreciation | ||||||||
- | - | - | - | 396 | 452 | 227 | 242 | 344 |
Write-down on long lived assets (Note 5) | ||||||||
- | - | - | - | - | 107 | - | 36 | - |
Expenses | ||||||||
- | - | - | - | 8,346 | 10,224 | 8,278 | 7,511 | 3,257 |
Loss from operations | ||||||||
- | - | - | - | -6,818 | -10,117 | -7,776 | -6,052 | -2,627 |
Fair value adjustment of derivative liabilities | ||||||||
- | - | - | - | -3,889 | 3,841 | 5,346 | 223 | 286 |
Financing expense (Note 10) | ||||||||
- | - | - | - | 115 | - | 2,357 | - | - |
Net foreign exchange gain (loss) | ||||||||
- | - | - | - | -359 | 181 | -70 | 138 | 587 |
Interest income | ||||||||
- | - | - | - | 2 | 20 | 60 | 27 | 1 |
Interest expense | ||||||||
- | - | - | - | 314 | 63 | 83 | 98 | 87 |
Net loss and comprehensive loss | ||||||||
- | - | - | - | -11,495 | -6,136 | -4,880 | -5,761 | -1,838 |
Foreign exchange translation adjustment | ||||||||
- | - | - | - | 524 | -124 | 110 | 116 | -727 |
Comprehensive loss | ||||||||
- | - | - | - | -10,970 | -6,261 | -4,769 | -5,644 | -2,566 |
Loss per common share, basic and diluted | ||||||||
-0.29 | -0.38 | -0.31 | -0.17 | -0.58 | -0.36 | -0.33 | -0.53 | -0.19 |
Weighted average number of common shares outstanding, basic and diluted | ||||||||
31,014 | 26,699 | 23,767 | 23,050 | 19,671 | 17,258 | 14,994 | 10,907 | 9,512 |